4.5 Article

Simulation and modeling of physiological processes of vital organs in organ-on-a-chip biosystem

期刊

出版社

ELSEVIER
DOI: 10.1016/j.jksus.2021.101710

关键词

Biomaterials; Microfluidics; Modeling; Organ-on-a-chip; Tissue engineering

向作者/读者索取更多资源

Organ-on-a-chip biosystems are microfluidic devices that mimic the functions of different organs and create physiological models. They have diverse applications in the field of biomedicine and are crucial for disease modeling and drug development.
The limited adequacy of animal cell cultures and models to mimic the complexity of human bodies in lab-oratory conditions has emphasized researchers to find its quintessential bioelectronic alternative with improved competence. In this regard, tissue engineering has emerged as one of the most precise bioma-terial technologies in terms of creating new tissues to model vital organs. An organ-on-a-chip biosystem has shown a plethora of applications in tissue engineering and drug delivery. Organ-on-a-chip is a microfluidic device that provides a completely controlled microenvironment, similar to the natural tis-sues for the cultured cells of an organ, by amalgamating cell biology and biomaterial science. The device contains several microchambers and microchannels embedded in a layer of a biocompatible polymer, such as polydimethylsiloxane. Microchambers house the cells, while microchannels provide nutrients and growth factors. Over the past few years, organ-on-a-chip technology has displayed ample applica-tions in the field of biomedicine, not only by simulating the normal functions of disparate organs, but also by understanding the inter-relation between diversified systems. In this review, we have spotlighted recent advancements and applications of organ-on-a-chip biosystems to construct physiological models for the heart, lung, kidney, liver, and brain. Part of this review is also concentrated on abridging the des-perate essentiality as well as future perspectives of organ-on-a-chip technology in biomedicine, disease modeling, and drug development process. (c) 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据